Article

Analytic validation of an<i>FGFR</i>-focused cell-free DNA liquid biopsy assay (FGFR-Dx)

2024-09-01

Abstract excerpt

<h4>ABSTRACT</h4> Commercial liquid biopsy assays are routinely used by oncologists to monitor disease response and resistance to therapy. Additionally, in cases where tumor tissue is not available, clinicians may rely on cell-free DNA (cfDNA) testing as a surrogate for comprehensive tumor testing. While some gene rearrangements are well detected, current commercial liquid biopsy assays exhibit low sensitivity for...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 2eca85fe-3838-5caf-ae57-7daa7ff30930
DOI: 10.1101/2024.09.01.24312783

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Analytic validation of an<i>FGFR</i>-focused cell-free DNA liquid biopsy assay (FGFR-Dx)DOI 10.1101/2024.09.01.24312783Read

Circulating Tumor DNA Enables Sensitive Detection of Actionable Gene Fusions and Rearrangements Across Cancer TypesSemantic proximity Read

Validation of a liquid biopsy assay with molecular and clinical profiling of circulating tumor DNASemantic proximity Read

Clinical and analytical validation of FoundationOne Liquid CDx, a novel 324-Gene cfDNA-based comprehensive genomic profiling assay for cancers of solid tumor origin.Semantic proximity Read

Pan-tumor landscape of fibroblast growth factor receptor 1-4 genomic alterationsSemantic proximity Read

Analytical Validation of a Pan-Cancer NGS Assay for In-House Liquid Biopsy Testing: An International Multicenter StudySemantic proximity Read

Incidental detection of FGFR3 fusion via liquid biopsy leading to earlier diagnosis of urothelial carcinomaSemantic proximity Read

Validation of a DNA-Based Next-Generation Sequencing Test for Molecular Diagnostic Variant and Fusion Detection in Formalin-Fixed, Paraffin-Embedded Tissue Specimens and Liquid Biopsy Plasma/Cell-Free DNA Samples.Semantic proximity Read

FGFR2 testing in cholangiocarcinoma: translating molecular studies into clinical practice.Semantic proximity Read

Enhanced specificity of high sensitivity somatic variant profiling in cell-free DNA via paired normal sequencing: design, validation, and clinical experience of the MSK-ACCESS liquid biopsy assaySemantic proximity Read

Clinical Validation of Whole Genome Sequencing for Cancer Diagnostics.Semantic proximity Read

Analytical validation of a next generation sequencing liquid biopsy assay for high sensitivity broad molecular profiling.Semantic proximity Read

Analytical and clinical validation of an amplicon-based next generation sequencing assay for ultrasensitive detection of circulating tumor DNASemantic proximity Read